Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DRAFFT 2 logo

The DRAFFT2 –Distal Radius Acute Fracture Fixation Trial 2 has now opened its first 2 sites for recruitment. Peterborough City Hospital and Royal Stoke University Hospital are now recruiting patients for the trial which is comparing two different ways of fixing bones within the broken wrist: K-wires and plaster cast.

Most fractures can be treated without the need for surgery. However, for the more serious wrist injuries, the treating surgeon may recommend an operation to restore the normal position of the wrist bones. This study is for patients who are having surgery for their broken wrist.

Both techniques are used routinely throughout the NHS, but we don’t know which one works best.

  • This is a multi-centre, multi-surgeon, parallel, two-arm, randomised controlled trial. It is planned to run across 16 sites in the UK and recruit 476 patients.
  • Patients over the age of 16 with a dorsally displaced fracture of the distal radius are potentially eligible for the trial.
  • We will ask all patients to report their own recovery using a questionnaire at 3 months, 6 months and 12 months after the treatment. The trial will also collect important information for secondary outcomes on quality of life, complications, resource use, costs and comparative cost effectiveness.

For more information and contacts, please visit https://www.ndorms.ox.ac.uk/clinical-trials/current-trials-and-studies/drafft-2

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.